Nosocomial pneumonia

Clinical Intensive Care

Volumn 12, Issue 3, 2001, Pages 115-126

  Higgins, T L ^a  

^a BAYSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CEFEPIME; CEFOPERAZONE; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEFUROXIME AXETIL; CEPHALOSPORIN DERIVATIVE; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CORTICOSTEROID; DALFOPRISTIN PLUS QUINUPRISTIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MEROPENEM; METICILLIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TIMENTIN; TOBRAMYCIN; TOBRAMYCIN SULFATE; VANCOMYCIN;

ABDOMINAL SURGERY; ACINETOBACTER; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; BACTERIAL COLONIZATION; CANDIDIASIS; COMA; CORTICOSTEROID THERAPY; DIABETES MELLITUS; DRUG MEGADOSE; FIBEROPTIC BRONCHOSCOPY; HEAD INJURY; HOSPITAL INFECTION; HUMAN; INFECTION PREVENTION; INTENSIVE CARE UNIT; INTUBATION; KIDNEY FAILURE; LENGTH OF STAY; LUNG ASPIRATION; LUNG DISEASE; LUNG LAVAGE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; MORTALITY; PNEUMONIA; PSEUDOMONAS AERUGINOSA; REVIEW; RISK FACTOR; THORAX RADIOGRAPHY; TREATMENT PLANNING; VENTILATOR;

EID: 0034917580     PISSN: 09563075     EISSN: None     Source Type: Journal    
DOI: 10.3109/tcic.12.3.115.126     Document Type: Review

References (67)

1. Hospital-acquired pneumonia in adults: Diagnosis, assessment of severity, initial antimicrobial therapy, and preventative strategies
2. Epidemiology of nosocomial pneumonia: New perspectives on an old disease
3. Guideline for prevention of nosocomial pneumonia
4. Nosocomial pneumonia in patients receiving continuous mechanical ventillation
5. Risk factors and outcome of nosocomial infections: Results of a matched case-control study of ICU patients
6. Influence of nosocomial infection on mortality rate in an intensive care unit
7. Nosocomial pneumonia in Medicare patients. Hospital costs and reimbursement patterns under the prosepctive payment system
8. Incidence of and risk fators for ventilator-associated pneumonia in critically ill patients
9. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: A randomized trial
10. Nosocomial infection in an intensive-care unit: Identification of risk factors
11. Nosocomial pneumonia in patients undergoing heart surgery
12. Patient transport from intensive care increases the risk of developing ventilator-associated pneumonia
13. Nosocomial pneumonia and mortality among patients in intensive care units
14. Nosocomial bronchopneumonia in the critically ill: Histologic and bacteriologic aspects
15. Detection of nosocomial lung infection in ventilated patients: Use of a protected specimen brush and quantitative culture techniques in 147 patients
16. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia
17. Bacteremic nosocomial pneumonia
18. Elastin fibers in the sputum of patients with necrotizing pneumonia
19. The diagnosis of ventilator-associated pneumonia. A comparison of histologic, microbiologic and clinical criteria
20. Invasive diagnostic testing is not needed routinely to manage suspected ventilator-associated pneumonia
21. Analysis of charges associated with diagnosis of nosocomial pneumonia: Can routine bronchoscopy be justified?
22. Comparison of direct examination of three types of bronchoscopy specimens used to diagnose nosocomial pneumonia
23. The polymerase chain reaction in the diagnosis and evaluation of pulmonary infections
24. Quality of care, process and outcomes in elderly patients with pneumonia
25. Management of community-acquired pneumonia in the era of pneumococcal resistance
26. Risk factors for Staphylococcus aureus nosocomial pneumonia in critically ill patients
27. Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes
28. Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia
29. Nosocomial pneumonia with isolation of anaerobic bacteria in ICU patients: Therapeutic considerations and outcome
30. A polyclonal outbreak of predominantly VanB vancomycin-resistant enterococci in Northeast Ohio
31. Empiric treatment of hospital-acquired lower respiratory tract infections with meropenem or ceftazidime with tobramycin: A randomized study
32. Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients
33. Enterobacter bacteremia: Clinical features and emergence of antibiotic resistance during therapy
34. Pharmacodynamics of antimicrobial agents as a basis for determining dosage regimens
35. Once-daily aminoglycoside dosing in immunocompetent adults: A meta-analysis
36. A study of the etiologies and treatment of nosocomial pneumonia in a community-based teaching hospital
37. Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics
38. Follow-up protected specimen brushes to assess treatment in nosocomial pneumonia
39. When pneumonia fails to resolve: Risk factors and diagnostic options
40. Significance of the isolation of Candida species from respiratory samples in critically ill, non-neutropenic patients
41. Practice guidelines for the treatment of candidiasis
42. The efficacy of influenza vaccine in elderly persons: A meta-analysis and review of the literature
43. Hand-washing patterns in medical intensive care units
44. Is hand washing really needed in an intensive care unit?
45. Contamination of mechanical ventilators with tubing changes every 24 or 48 hours
46. Risk factors and clinical relevance of nosocomial maxillary sinusitis in the critically ill
47. Pulmonary aspiration of gastric contents in patients receiving mechanical ventilation: The effect of body position
48. Ventilator-associated pneumonia. A multivariate analysis
49. Continuous aspiration of subglottic secretions in preventing ventilator-associated pneumonia
50. The efficacy of an oscillating bed in the prevention of lower respiratory tract infection in critically ill victims of blunt trauma
51. Effect of air-supported, continuous postural oscillation on the risk of early ICU pneumonia in nontraumatic critical illness
52. Ventilator-associated sinusitis. Microbiological results of sinus aspirates in patients on antibiotics
53. Alteration of normal gastric flora in critically ill patients receiving antacid and cimetidine therapy
54. Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers
55. Clinical trials of selective decontamination of the digestive tract: Review
56. Prevention of infection in critically ill patients by selective decontamination of the digestive tract
57. A controlled trial in intensive care units of selective decontamination of the digestive tract with nonabsorbable antibiotics
58. Utility of selective digestive decontamination in mechanically ventilated patients
59. Effectiveness of antibiotic prophylaxis in critically ill adult patients: Systematic review of randomized controlled trials
60. Effectiveness of selective digestive tract decontamination to control an outbreak of nosocomial pneumonia caused by Pseudomonas aeruginosa in mechanically ventilated patients
61. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis
62. Prophylactic intravenous administration of standard immune globulin as compared with core-lipopolysaccharide immune globulin in patients at high risk of postsurgical infection
63. Antimicrobial resistance in enterococci isolated from turkey flocks fed virginiamycin
64. Antimicrobial drug resistance
65. Novel plasmid-mediated β-lactamases in enterobacteriaceae: Emerging problems for new β-lactam antibiotics
66. Prevalence of anti-microbial resistance among respiratory tract isolates of S. pneumoniae in North America
67. Scheduled change of antibiotic classes. A strategy of decrease the incidence of ventilator-associated pneumonia